IR情報

2024/04/12~2024/09/05

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2024
09/051,0201,0441,0131,039+1.46%4,615,6001兆4482億+3.28%
09/041,0161,0301,0121,024-2.1%5,133,2001兆4273億+1.59%
09/0310:00 (開示事項の経過)スウェーデン製薬企業Calliditas Therapeutics ABに対する公開買付けの結果および子会社の異動に関するお知らせ
09/031,0371,0471,0331,046+0.77%3,233,5001兆4580億+3.56%
09/021,0401,0421,0311,038+0.58%2,234,0001兆4469億+2.67%
08/301,0301,0381,0271,032+0.19%5,191,6001兆4385億+2.08%
08/291,0381,0391,0281,030-0.39%9,190,2001兆4357億+1.88%
08/281,0301,0351,0251,034-0.39%2,767,1001兆4413億+2.38%
08/271,0381,0451,0321,038+0.29%2,296,5001兆4469億+2.67%
08/261,0331,0371,0241,035+0.19%2,289,5001兆4427億+2.37%
08/231,0301,0421,0271,033+1.18%3,622,7001兆4399億+2.08%
08/221,0211,0241,0141,021+0.69%2,883,0001兆4232億+0.79%
08/211,0081,0161,0041,0140%1,915,5001兆4134億-0.1%
08/201,0221,0261,0091,014+0.5%3,011,1001兆4134億-0.2%
08/191,0201,0311,0071,009-1.18%2,510,3001兆4064億-0.88%
08/161,0201,0251,0121,021+2.41%3,111,1001兆4232億+0.1%
08/159931,003992997+0.91%3,993,4001兆3897億-2.35%
08/14976988973988+0.61%4,434,4001兆3772億-3.42%
08/13964984963982+3.26%5,923,5001兆3688億-4.1%
08/09979979938951-1.14%6,596,0001兆3256億-7.22%
08/08950983945962+0.73%5,614,3001兆3409億-6.42%
08/07946979941955-1.04%7,651,5001兆3312億-7.28%
08/06964984938965+6.63%9,534,7001兆3451億-6.58%
08/05960977901905-8.59%13,227,6001兆2615億-12.64%
08/029981,002982990-4.07%8,226,9001兆3799億-4.9%
08/011,0711,0731,0181,032-5.67%7,330,1001兆4385億-0.96%
07/3112:30 2024年度第1四半期決算説明資料
07/3112:30 第2四半期(累計)連結業績予想の修正に関するお知らせ
07/3112:30 2025年3月期第1四半期決算短信〔日本基準〕(連結)
07/311,0601,1101,0541,094+3.21%10,650,1001兆5249億+4.99%
07/301,0601,0661,0511,060-0.47%3,385,6001兆4775億+1.92%
07/291,0581,0651,0511,065+2.8%3,496,2001兆4845億+2.6%
07/261,0361,0471,0291,036-0.29%4,188,9001兆4441億+0.1%
07/251,0311,0421,0191,039+1.86%6,605,6001兆4482億+0.58%
07/241,0331,0341,0181,020-1.83%4,180,2001兆4218億-1.07%
07/231,0431,0461,0341,039-0.1%3,627,3001兆4482億+0.87%
07/221,0611,0621,0401,040-1.89%3,100,5001兆4496億+1.07%
07/191,0571,0601,0461,060-0.66%6,677,3001兆4775億+3.11%
07/1816:00 (開示事項の経過)Calliditas Therapeutics ABに対する株式公開買付け開始について
07/181,0551,0681,0541,067-0.09%3,963,4001兆4873億+4.1%
07/1715:00 完全子会社である旭フアイナンス株式会社の吸収合併(簡易吸収合併・略式吸収合併)に関するお知らせ
07/171,0581,0691,0561,068+2.3%4,326,0001兆4887億+4.3%
07/161,0541,0541,0391,044-0.95%3,325,5001兆4552億+2.15%
07/121,0491,0631,0441,054-1.68%5,414,6001兆4692億+3.23%
07/111,0671,0731,0641,072+2%5,500,0001兆4942億+5.1%
07/101,0581,0581,0441,051+0.77%6,018,2001兆4650億+3.24%
07/091,0381,0461,0361,043+2.66%5,944,4001兆4538億+2.66%
07/081,0091,0181,0061,016+0.69%4,103,9001兆4162億0%
07/051,0141,0161,0051,009-0.69%4,619,9001兆4064億-0.79%
07/041,0201,0221,0161,016-0.29%4,862,7001兆4162億-0.1%
07/031,0221,0221,0151,019-0.59%6,044,1001兆4204億+0.2%
07/021,0291,0291,0141,025-0.1%7,493,4001兆4287億+0.79%
07/011,0371,0391,0151,026-0.48%6,822,9001兆4301億+0.79%
06/281,0341,0371,0261,031-0.19%5,208,7001兆4371億+1.18%
06/271,0251,0331,0241,033+0.78%4,754,0001兆4399億+1.27%
06/261,0261,0271,0141,025-0.77%6,503,5001兆4287億+0.49%
06/251,0201,0351,0191,033+1.57%5,701,8001兆4399億+1.18%
06/241,0051,0211,0031,017+2.11%6,469,3001兆4176億-0.59%
06/219871,001982996+1.84%10,759,1001兆3883億-2.73%
06/20993997977978-2.4%7,049,7001兆3632億-4.68%
06/191,0001,0029921,002+0.6%3,436,2001兆3967億-2.53%
06/181,0001,009995996-0.3%4,423,4001兆3883億-3.3%
06/171,0021,005997999-0.99%4,245,1001兆3925億-3.29%
06/141,0001,0149971,009+0.4%4,718,5001兆4064億-2.61%
06/131,0171,0181,0021,005-1.76%3,869,6001兆4009億-3.18%
06/121,0181,0241,0131,023-0.1%3,133,8001兆4259億-1.92%
06/111,0251,0271,0181,024-0.1%4,095,7001兆4273億-2.1%
06/101,0261,0321,0211,025-0.1%2,927,7001兆4287億-2.29%
06/071,0131,0301,0091,026+0.88%3,272,1001兆4301億-2.56%
06/061,0141,0211,0061,017+0.2%4,586,2001兆4176億-3.69%
06/051,0251,0261,0111,015-1.84%3,546,5001兆4148億-4.15%
06/041,0351,0381,0291,034-0.29%4,559,8001兆4413億-2.54%
06/031,0341,0451,0321,037+1.17%3,969,8001兆4455億-2.45%
05/311,0181,0331,0151,025+1.69%10,889,6001兆4287億-3.67%
05/301,0161,0191,0041,008-1.95%7,218,8001兆4050億-5.53%
05/291,0501,0531,0261,028-2.1%5,678,2001兆4329億-4.01%
05/2815:15 スウェーデン製薬企業Calliditas Therapeutics ABの買収について
05/281,0481,0611,0471,050+0.67%2,190,2001兆4636億-2.23%
05/271,0451,0511,0351,043-0.19%2,892,0001兆4538億-3.07%
05/241,0351,0511,0321,045-0.67%3,221,6001兆4566億-3.06%
05/231,0411,0571,0371,052+0.48%3,122,3001兆4664億-2.68%
05/221,0611,0671,0471,047-2.79%3,894,6001兆4594億-3.41%
05/211,0501,0821,0501,077+2.77%5,563,6001兆5012億-0.83%
05/201,0491,0601,0431,048+0.96%2,985,4001兆4608億-3.68%
05/171,0211,0391,0171,038+0.58%3,846,6001兆4469億-4.86%
05/161,0461,0491,0271,032-1.43%4,228,9001兆4385億-5.75%
05/151,0671,0691,0441,047-2.24%3,547,2001兆4594億-4.64%
05/141,0641,0761,0621,071+0.66%3,790,5001兆4929億-2.64%
05/1316:20 (訂正)「2023年度決算説明資料」の一部訂正について
05/131,0581,0671,0491,064-0.93%5,991,3001兆4831億-3.27%
05/101,0801,1091,0671,074-5.21%7,436,0001兆4970億-2.45%
05/0912:30 連結決算における持分法による投資損失および減損損失の計上、個別決算における関係会社株式評価損の計上並びに通期連結業績予想と実績値の差異に関するお知らせ
05/0912:30 (開示事項の経過)連結子会社間の株式譲渡による株式売却損(個別)、法人税、住民税及び事業税・法人税等調整額(個別および連結)の計上について
05/0912:30 2023年度決算説明資料
05/0912:30 2024年3月期決算短信〔日本基準〕(連結)
05/091,1001,1691,0921,133+3.38%12,513,2001兆5793億+2.91%
05/081,1051,1051,0891,096-0.81%3,522,8001兆5277億-0.27%
05/071,1051,1111,0941,105+0.36%4,235,9001兆5402億+0.55%
05/021,1051,1141,0991,101-0.45%3,723,8001兆5347億+0.18%
05/011,1001,1111,0931,106+0.45%4,239,4001兆5416億+0.45%
04/301,0881,1021,0801,101+3.09%5,595,3001兆5347億-0.09%
04/261,0551,0741,0521,0680%6,179,1001兆4887億-3.17%
04/251,0901,0991,0631,068-0.56%6,151,8001兆4887億-3.44%
04/2415:30 リチウムイオン電池用セパレータ事業に係る孫会社の増資(特定子会社化)に関するお知らせ
04/241,1001,1121,0461,074-2.27%9,739,5001兆4970億-3.07%
04/231,1151,1171,0981,099-0.9%1,819,9001兆5319億-0.99%
04/221,1121,1131,1011,109+1.28%2,244,5001兆5458億-0.18%
04/191,1001,1001,0801,095-1.35%2,555,1001兆5263億-1.44%
04/181,0991,1131,0991,110+1.09%1,930,7001兆5472億-0.18%
04/171,1131,1141,0951,098-1.08%2,203,6001兆5305億-1.08%
04/161,1091,1201,1051,110-0.63%2,992,4001兆5472億+0.09%
04/151,1031,1191,0961,117+0.72%2,338,9001兆5570億+0.9%
04/121,1221,1271,1081,109-1.68%3,028,9001兆5458億+0.36%